RESEARCH TRIANGLE — Redbud Labs, which has developed a unique diagnostic tool, has raised nearly $400,000 of an equity round targeted at $1 million, according to a regulatory filing.
At the the February 2018 conference, “InnovationDelivers A Better Tomorrow,” in which CED, the North Carolina Biotechnology Center and NCBIO partnered for an annual showcase of new life science companies to pitch, CEO Richard Spero said the company has raised nearly $7 million so far.
The company received a $3,000 internship grant from the Biotech Center.
The University of North Carolina at Chapel Hill spinout developed a unique diagnostic tool called Redbud Posts.
It is a micro-electromechanical system technology conceived in Professor Richard Superfine’s research group at UNC to mimic the behavior of cilia, the microscopic hair-like structures used to manipulate fluids in a wide range of organisms, from bacteria to cells lining the human airway.
According to its web site,
Redbud Labs is a microfluidic chip manufacturer. It says it is pioneering a new category of consumable components with MXR, the world’s first fully modular microfluidic mixer. World-class biotechnology firms use MXR to boost assay performance.
The company is headquartered at The Frontier in Research Triangle Park
